Stock listing
Korro Bio, Inc.
Selected listing: KRRO · NASDAQ · USD · US
Korro Bio, Inc. (NASDAQ:KRRO), Health Technology. Latest release Oct 5, 2026: Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR)…
- Ticker
- NASDAQ:KRRO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Korro Bio, Inc.
Korro Bio, Inc. (KRRO) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Korro Bio, Inc.
Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR) for KRRO-121
October 5, 2026
Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR) for KRRO-121
October 4, 2026
Korro Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 6, 2026
Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 10, 2026
Korro to Present at the 2026 Jefferies Global Healthcare Conference
May 26, 2026